Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 37 of the 64 sources its claims cite were checked for support.
Abstract
The expression of oncogenic ras in normal human cells quickly induces an aberrant proliferation response that later is curtailed by a cell cycle arrest known as cellular senescence. Here, we show that cells expressing oncogenic ras display an increase in the mitochondrial mass, the mitochondrial DNA, and the mitochondrial production of reactive oxygen species (ROS) prior to the senescent cell cycle arrest. By the time the cells entered senescence, dysfunctional mitochondria accumulated around the nucleus. The mitochondrial dysfunction was accompanied by oxidative DNA damage, a drop in ATP levels, and the activation of AMPK. The increase in mitochondrial mass and ROS in response to oncogenic ras depended on intact p53 and Rb tumor suppression pathways. In addition, direct interference with mitochondrial functions by inhibiting the expression of the Rieske iron sulfur protein of complex III or the use of pharmacological inhibitors of the electron transport chain and oxidative phosphorylation was sufficient to trigger senescence. Taking these results together, this work suggests that mitochondrial dysfunction is an effector pathway of oncogene-induced senescence.
Overview
CoChat Summary
TL;DR
Oncogenic Ras expression in normal human IMR90 fibroblasts increases mitochondrial mass, mtDNA, and mitochondrial ROS before senescence, then leads to depolarized perinuclear mitochondria, oxidative DNA damage, ATP loss, and AMPK activation. These mitochondrial changes require p53 or Rb, and direct mitochondrial interference by RISP knockdown or rotenone/oligomycin is sufficient to trigger senescence, suggesting mitochondrial dysfunction is an effector pathway of oncogene-induced senescence.
Key findings
- RasV12 induced mitochondrial superoxide by day 2 after selection and higher levels by day 8; mtDNA increased after day 2, and mitochondrial biogenesis genes NRF2a, PGC1α, PGC1β, and TFAM were induced before senescence, with NRF1 increased later.
- By senescence at day 8, Ras-expressing cells showed perinuclear depolarized mitochondria by JC-1, H2O2 accumulation, 8-OHdG oxidative DNA damage, SOD2/catalase induction by day 6, decreased ATP equivalent to oligomycin treatment, active AMPK, and higher glucose consumption than controls.
- p53 or Rb was required: shp53 alone or E7 alone did not prevent Ras-induced mitochondrial mass/ROS, E7 partially reduced them, and shp53 plus E7 prevented ROS, mitochondrial mass, and senescence; shp16 with shp53 also prevented these changes, and E1A inhibited Ras-dependent mitochondrial mass/ROS.
- Direct mitochondrial dysfunction triggered senescence: RISP knockdown caused growth arrest by 6 days with SA-β-Gal, G1 arrest, low BrdU, DNA damage foci, PML bodies, hypophosphorylated Rb, low Mcm6, p21/HDM2 induction, increased ROS/mtDNA, decreased ATP, and AMPK activation; rotenone and oligomycin inhibited growth, with rotenone more efficient at inducing SA-β-Gal, PML bodies, superoxide, and mitochondrial mass.
Methods
- Normal human diploid IMR90 fibroblasts were infected with retroviral Ha-RasV12 or controls, selected with puromycin, and analyzed at 2 days and 8 days after selection; additional experiments used shRNAs against p53, p16, or RISP, E7, E1A, rotenone, and oligomycin.
- Assays included qPCR for mtDNA/nuDNA and gene expression; FACS and immunofluorescence for MitoFluor Green, JC-1, MitoSox, DHE, DCFDA, BrdU/PI, SA-β-gal, 8-OHdG, γH2AX, PML, and catalase; Western blotting for AMPK, phospho-AMPK, ACC, p53, p21, HDM2, Ras, Rb, RISP, and tubulin; plus ATP and glucose-consumption measurements.
- Main analysis compared Ras-expressing versus control cells at pre-senescent and senescent time points, tested p53/Rb pathway requirements, and tested sufficiency of mitochondrial dysfunction via RISP knockdown and mitochondrial inhibitors.
Limitations
- Stated: the authors cannot eliminate possible contributions of increased cellular ATPase activities or metabolic futile cycles to the ATP drop; the identity and role of perinuclear vacuoles remain to be investigated; it remains challenging to determine whether superoxide production or loss of membrane potential comes first; more studies are required to link p53 and Rb to mitochondria during OIS; further studies are needed for tumor-selective mitochondrial strategies.
- Stated: antioxidant treatment retarded but did not completely prevent OIS (data not shown).
- Evident from the text: findings are largely in one normal human fibroblast line (IMR90) with retroviral RasV12, with no in vivo tumor model; several conclusions rely on pharmacological inhibitors and shRNA, and some supporting results are in supplemental figures or not shown.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
23 Valid · 1 Not valid · 13 Not checked · 95 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It has been demonstrated that mitochondria play a critical role in replicative senescence, and several mitochondrial changes, including an increase in the production of reactive oxygen species (ROS), were reported in cells with short telomeres (34, 35).”
What the sources say
- Supportedcites [34] source
The Introduction links short telomere length with mitochondrial dysfunction in senescent-phenotype fibroblasts. The Results section “Mitochondrial Dysfunction in Senescent Fibroblasts” reports increased mitochondrial superoxide and other mitochondrial changes, including reduced membrane potential and increased mitochondrial mass. No page numbers are available in our copy. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [35] source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“OIS is phenotypically similar to the senescence response triggered by short telomeres, also known as replicative senescence (6).”
What the sources say
- Supportedcites [6] source
The paper describes dysfunctional telomeres and overexpressed oncogenes as distinct triggers of the same cellular senescence response (Abstract; Good Citizens—Cells Senesce in Response to Potential Cancer-Causing Events, page unavailable). It also identifies telomere-shortening-induced arrest as replicative senescence. This supports the broad claim of phenotypic similarity, though the passages do not compare individual phenotypic features. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In turn, the loss of membrane potential may increase ROS production (4).”
What the sources say
- Partly supportedcites [4] sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports that PTP opening, which uncouples mitochondria, increased H₂O₂ production when NADH was supplied. It also reports that PTP opening inhibited H₂O₂ production without that supply, while uncoupling has been shown to decrease ROS. The paper attributes the increase to a change in complex I, not to loss of membrane potential itself. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It has been demonstrated that mitochondria play a critical role in replicative senescence, and several mitochondrial changes, including an increase in the production of reactive oxygen species (ROS), were reported in cells with short telomeres (34, 35).”
What the sources say
- Supportedcites [34] source
The Introduction reports that reducing mitochondrial superoxide generation delayed telomere damage and extended replicative lifespan. The Discussion concludes that mitochondrial ROS production is a determinant of telomere-dependent replicative senescence. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [35] source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“OIS also involves the DNA damage response (2, 15, 28), but the mechanism of DNA damage and the contribution of mitochondria to it are unclear.”
What the sources say
- Not checked — no full text of the sourcecites [2] source
- Not checked — no full text of the sourcecites [15] source
- Supportedcites [28] source
The section “STAT5A and RasV12 induce a constitutive activation of the DNA damage signaling pathway” reports DNA damage foci in cells induced to senesce by either oncogene. The “ODDI persist in cells that bypassed senescence” section also concludes that oncogenic activity activates the DNA damage signaling pathway, which supports the attributed claim. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
70 more claims · 4 with their cited sources checked
Create a free account to see all 132 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 38
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sustained activation of 5′AMP-activated protein kinase (AMPK), a major bioenergetic sensor, is a hallmark of senescence (Moiseeva et al., 2009) and can induce a senescence arrest”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ROS can damage DNA directly or through oxidative lesions that increase replication fork collapse by preventing its progression, thereby exacerbating the formation of DNA breaks and DDR activation [121,122].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the early stage of senescence, mitochondria do not function properly and display impaired oxidative phosphorylation capacity and reduced inner membrane potential, resulting in ROS overproduction [120,121,208,211].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [121]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Dysfunctional mitochondria can induce cellular senescence in culture (Moiseeva et al., 2009; Wang et al., 2003) and in vivo (Dai et al., 2010; Kang et al., 2013).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial ROS can damage nuclear DNA, thus activating a DNA damage response that induces senescence (Moiseeva et al., 2009; Passos et al., 2010).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 8×
“Ras-induced senescence in human cells can be mediated by either the p53 or the Rb family of tumor suppressors (28, 29, 43, 48).”
BackgroundInfluentialA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“Replicative senescence is, in essence, the consequence of a DNA damage response triggered by short telomeres (11).”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Thus, we used an shRNA against p16INK4 (32) alone or in combination with shp53 to evaluate the roles of the p16/Rb and p53 pathways in the mitochondrial changes induced by oncogenic ras.”
MethodActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 1×
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
Background
Cited by
Items 101–200 of 407
Xiong, Y., Yu, Y., Montani, J., Yang, Z., & Ming, X. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000096 · Cited by 98
The aging signature: a hallmark of induced pluripotent stem cells?
Rohani, L., Johnson, A. A., Arnold, A., & Stolzing, A. (2013) · Aging Cell · doi:10.1111/acel.12182 · Cited by 102
Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
Seyfried, T. N., Yu, G. W., Maroon, J. C., & D’Agostino, D. P. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0178-2 · Cited by 94
HIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 99
“dysfunction is an inducer of cellular senescence (Moiseeva et al., 2009; Velarde et al., 2012; Wiley et al., 2016).”
Jiang, Y., Chen, X., Tian, W., Yin, X., Wang, J., & Yang, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.368 · Cited by 85
“8-hydroxy-20-deoxyguanosine detection was performed as previously described (Moiseeva et al, 2009).”
BackgroundMethodCrosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84
Mitochondria and cellular senescence: Implications for musculoskeletal ageing
Habiballa, L., Salmonowicz, H., & Passos, J. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.417 · Cited by 82
Cellular Senescence in Sarcopenia: Possible Mechanisms and Therapeutic Potential
He, Y., Xie, W., Li, H., Jin, H., Zhang, Y., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.793088 · Cited by 93
Targeting reactive oxygen species in development and progression of pancreatic cancer
Durand, N., & Störz, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1261017 · Cited by 83
“However, as a mechanism for keeping ROS levels within narrow limits, where they drive hyperactivation of tumor-inducing signaling pathways, but do not trigger oncogene-induced senescence (OIS) or cell death, transformed cells often also upregulate their antioxidant defense capacity [48,49].”
BackgroundPascual-Ahuir, A., Manzanares-Estreder, S., & Proft, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9860841 · Cited by 81
“of respiratory complex I function, and increased mitochondrial ROS production [117, 118].”
Rodenak‐Kladniew, B., Castro, A., Stärkel, P., Galle, M., & Crespo, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117271 · Cited by 87
Seebacher, N. A., Lane, D. J. R., Richardson, D. R., & Jansson, P. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.201 · Cited by 82
Yarbro, J. R., Emmons, R. S., & Pence, B. D. (2020) · Immunometabolism · doi:10.20900/immunometab20200026 · Cited by 87
“Senescent and aged cells display a decreased ΔΨm, increased proton leakage, aberrant ROS generation, and an increase in TCA intermediates [91,92,135,138].”
BackgroundHIV TAT-mediated microglial senescence: Role of SIRT3-dependent mitochondrial oxidative stress
Thangaraj, A., Chivero, E. T., Tripathi, A., Singh, S., Niu, F., Guo, M.-L., Pillai, P., Periyasamy, P., & Buch, S. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101843 · Cited by 76
ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
Bellot, G. L., Liu, D., & Pervaiz, S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.06.007 · Cited by 81
Targeting metabolism in cellular senescence, a role for intervention
Nacarelli, T., & Sell, C. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.049 · Cited by 85
“A key observation in this study was that this response was accompanied by the accumulation of dysfunctional mitochondria around the nucleus (Moiseeva et al., 2009).”
BackgroundInfluentialAberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
Bongiovanni, D., Saccomani, V., & Piovan, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091904 · Cited by 84
“Conversely, multiple oncogenic signals, including RAS and MYC, can generate metabolic stress [254,255] and AMPK may promote cancer cell survival under these conditions.”
BackgroundRegulation of Mitophagy by Sirtuin Family Proteins: A Vital Role in Aging and Age-Related Diseases
Wan, W., Hua, F., Fang, P., Li, C., Deng, F., Chen, S., Ying, J., & Wang, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.845330 · Cited by 85
“Altered expression of Sirtuins is found in HD models and affects mitochondrial dynamics (including mitophagy) (Neo and Tang, 2018; Franco-Iborra et al., 2021; Naia et al., 2021; Sonsky et al., 2021).”
BackgroundEglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
Zhang, J., Wang, C., Chen, X., Takada, M., Fan, C., Zheng, X., Wen, H., Liu, Y., Wang, C., Pestell, R. G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591437 · Cited by 72
“…that mitochondria still play important functions in cancer cells for sustained tumor growth (Nakashima et al , 1984; Guppy et al , 2002; Gatenby & Gillies, 2004; Zu & Guppy, 2004; Moreno-Sanchez et al , 2007; Weinberg et al , 2010; Guo et al , 2011, 2013; Wallace, 2012; Strohecker et al , 2013).”
InfluentialMitochondrial fatty acid oxidation drives senescence
Yamauchi, S., Sugiura, Y., Yamaguchi, J., Zhou, X., Takenaka, S., Odawara, T., Fukaya, S., Fujisawa, T., Naguro, I., Uchiyama, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado5887 · Cited by 82
“It has long been known that senescence is accompanied by an increase in mitochondrial reactive oxygen species (ROS) levels and a decrease in membrane potential ( 14 ).”
Lee, W., & Lee, D. G. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1407412 · Cited by 76
“A change in mitochondrial mass has also been shown to enhance oxidative conditions leading to apoptosis [24,53,54].”
BackgroundParallel pathways in RAF-induced senescence and conditions for its reversion
Jeanblanc, M., Ragu, S., Gey, C., Contrepois, K., Courbeyrette, R., Thuret, J., & Mann, C. (2011) · Oncogene · doi:10.1038/onc.2011.481 · Cited by 79
Glycerophospholipid profile in oncogene-induced senescence
Cadenas, C., Vosbeck, S., Hein, E., Hellwig, B., Langer, A., Hayen, H., Franckenstein, D., Büttner, B., Hammad, S., Marchan, R., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.11.008 · Cited by 79
“Recently, mitochondrial dysfunction has been observed in other models of oncogene-induced senescence [42] and it was suggested that loss of mitochondrial function may be an effector pathway of oncogene-induced senescence [42].”
BackgroundEndothelial Senescence: A New Age in Pulmonary Hypertension
Culley, M. K., & Chan, S. Y. (2022) · Circulation Research · doi:10.1161/circresaha.121.319815 · Cited by 75
Rai, P. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.07.010 · Cited by 73
“Oncogenic Ras activation in lung fibroblasts is also associated with increased 8-oxo-dG levels [121].”
BackgroundEnergetic mitochondrial failing in vitiligo and possible rescue by cardiolipin
Dell’Anna, M. L., Ottaviani, M., Kovacs, D., Mirabilii, S., Brown, D. A., Cota, C., Migliano, E., Bastonini, E., Bellei, B., Cardinali, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13961-5 · Cited by 68
“As previously reported (Moiseeva et al., 2009), the relative quantification of mitochondrial DNA (mtDNA) over nuclear DNA (nuDNA) levels was determined using the difference in the threshold cycle values of nuclear TATA-box-binding protein region on chromosome 6 and the mitochondrial non-coding…”
MethodThe role of mitochondria in cellular senescence
Ghosh‐Choudhary, S. K., Liu, J., & Finkel, T. (2021) · The FASEB Journal · doi:10.1096/fj.202101462r · Cited by 70
Esencan, E., Beroukhim, G., & Seifer, D. B. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-01033-x · Cited by 87
Wang, H., Yuan, S., Zheng, Q., Zhang, S., Zhang, Q., Ji, S., Wang, W. J., Cao, Y., Guo, Y., Yang, X., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.025 · Cited by 69
A hydride transfer complex reprograms NAD metabolism and bypasses senescence
Igelmann, S., Lessard, F., Uchenunu, O., Bouchard, J., Fernandez-Ruiz, A., Rowell, M.-C., Lopes-Paciencia, S., Papadopoli, D., Fouillen, A., Ponce, K. J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.028 · Cited by 60
Self-citationWu, X., Jiang, L., Yu, M., An, X., Ma, R., & Yu, Z. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.06.005 · Cited by 63
“Data suggest that mitochondrial dysfunction is a general feature of cellular senescence and that has been reported to occur independently of the nature of the senescence stimuli [10,11].”
BackgroundCellular senescence and protein degradation: Breaking down cancer
Deschênes‐Simard, X., Lessard, F., Gaumont‐Leclerc, M., Bardeesy, N. M., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 71
Self-citationTanaka, H., Takebayashi, S., Sakamoto, A., Igata, T., Nakatsu, Y., Saitoh, N., Hino, S., & Nakao, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.021 · Cited by 60
The Emerging Role of Senescence in Ocular Disease
Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2583601 · Cited by 75
“(v) Multiple animal models are required to test potential senolytic drugs/senolytic cocktails and to understand the off-target effects of senolytic agents [56, 95, 102].”
BackgroundSenescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Battram, A. M., Bachiller, M., & Martín-Antonio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124346 · Cited by 69
Astrocyte senescence and metabolic changes in response to HIV antiretroviral therapy drugs
Cohen, J., D’Agostino, L., Wilson, J., Tuzer, F., & Torres, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00281 · Cited by 58
“Mitochondrial dysfunction is known to induce cellular senescence both in vitro and in vivo (Moiseeva et al., 2009), which made it worth looking at how HAART drugs affect the mitochondria in astrocytes.”
BackgroundInfluentialMitochondrial Dysfunction Meets Senescence
Gallage, S., & Gil, J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.005 · Cited by 67
“The authors show that MiDAS was not caused by accumulation of nuclear DNA damage (53BP1 foci) or oxidative stress as previously thought [2,3].”
BackgroundInfluentialCold atmospheric plasma causes a calcium influx in melanoma cells triggering CAP-induced senescence
Schneider, C., Gebhardt, L., Arndt, S., Karrer, S., Zimmermann, J. L., Fischer, M. J. M., & Bosserhoff, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-28443-5 · Cited by 64
From cancer metabolism to new biomarkers and drug targets
Chiaradonna, F., Moresco, R. M., Airoldi, C., Gaglio, D., Palorini, R., Nicotra, F., Messa, C., & Alberghina, L. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.006 · Cited by 69
Disease‐specific phenotypes in iPSC‐derived neural stem cells with POLG mutations
Liang, K. X., Kristiansen, C. K., Mostafavi, S., Vatne, G. H., Zantingh, G. A., Kianian, A., Tzoulis, C., Høyland, L. E., Ziegler, M., Pérez, R., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012146 · Cited by 64
“Dysfunctional mitochondria can induce cellular senescence both in in vitro culture (Moiseeva et al, 2009) and in vivo (Kang et al, 2013; Wiley et al, 2016).”
BackgroundNacarelli, T., Azar, A., Altinok, O., Orynbayeva, Z., & Sell, C. (2018) · GeroScience · doi:10.1007/s11357-018-0030-2 · Cited by 58
Proline restores mitochondrial function and reverses aging hallmarks in senescent cells
Choudhury, D., Rong, N., Kumar, H. V. S., Swedick, S., Samuel, R. Z., Mehrotra, P., Toftegaard, J., Rajabian, N., Thiyagarajan, R., Podder, A. K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113738 · Cited by 66
RAS signalling in energy metabolism and rare human diseases
Dard, L., Bellancé, N., Lacombe, D., & Rossignol, R. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.05.003 · Cited by 62
Hu, H., Zhao, R., He, Q., Cui, C., Song, J., Guo, X., Zang, N., Yang, M., Zou, Y., Yang, J., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101988r · Cited by 62
Onoe, S., Temma, T., Shimizu, Y., Ono, M., & Saji, H. (2014) · Cancer Medicine · doi:10.1002/cam4.252 · Cited by 52
“Mitochondria are key regulators of cell death through caspase-3 activation [3, 4, 13] and have been implicated in multiple aspects of tumorigenesis and tumor progression through activation of oncogenes such as Ras [25, 26] and Myc 780 ª 2014 The Authors.”
BackgroundLIPG‐promoted lipid storage mediates adaptation to oxidative stress in breast cancer
Cadenas, C., Vosbeck, S., Edlund, K., Grgas, K., Madjar, K., Hellwig, B., Adawy, A., Glotzbach, A., Stewart, J. D., Lesjak, M. S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32138 · Cited by 58
“An increase in ROS generation has been demonstrated in MCF-7/NeuT and other models of oncogene-induced senescence (OIS),(11,26) including lipid peroxides(11) as well as superoxide anions and hydrogen peroxide.(26) Thus, as expected, we confirmed the previously observed upregulation of thioredoxin reductase (TXNRD1)(11…”
BackgroundInhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells
Delfarah, A., Parrish, S., Junge, J. A., Yang, J., Seo, F., Li, S., Mac, J., Wang, P., Fraser, S. E., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005806 · Cited by 52
“Alterations in mitochondrial function can also induce senescence through 5 AMP-activated protein kinase– and p53– dependent pathways (17, 18).”
BackgroundLiceras-Boillos, P., García‐Navas, R., Ginel-Picardo, A., Anta, B., Pérez‐Andrés, M., Lillo, C., Gómez, C., Jimeno, D., Fernández‐Medarde, A., Baltanás, F. C., et al. (2016) · Oncogene · doi:10.1038/onc.2016.169 · Cited by 53
Fluorescence-Based Detection and Quantification of Features of Cellular Senescence
Cho, S., & Hwang, E. S. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-385493-3.00007-3 · Cited by 60
Nutrient sensing, growth and senescence
Carroll, B., & Korolchuk, V. I. (2018) · FEBS Journal · doi:10.1111/febs.14400 · Cited by 54
Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis
Yang, Y., Gao, Y., Zlatanou, A., Tateishi, S., Yurchenko, V., Rogozin, I. B., & Vaziri, C. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1456296 · Cited by 53
“Oxidative DNA damage activates RAD18 in replicating and non-replicating cells, and the TLS pathway clearly allows cells to tolerate ROS-induced genotoxicity [16,17,73].”
InfluentialSeyfried, T. N., & Chinopoulos, C. (2021) · Metabolites · doi:10.3390/metabo11090572 · Cited by 59
Wang, P., Han, L., Shen, H., Wang, P., Lv, C., Zhao, G., Niu, J., Xue, L., Wang, Q. J., Tong, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310972111 · Cited by 56
“Several positive ROS-generating feedback loops, such as ROS-protein kinase Cδ (PKCδ) loop (6), mitochondrial dysfunctional signaling (7), and DDB2-mediated pathway (8), were proposed to contribute to elevatedROS levels inRasOIS.”
BackgroundJailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 56
Song, N., Kim, A. J., Kim, H., Jee, H. J., Kim, M., Yoo, Y. H., & Yun, J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01003.x · Cited by 52
“In addition to organismic aging, recent studies have also demonstrated that mitochondria play an important role in cellular life span and the senescence process [35, 36].”
BackgroundPleiotropic actions of estrogen: a mitochondrial matter
Velarde, M. C. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00155.2012 · Cited by 56
Gruber, H. E., Watts, J. A., Hoelscher, G. L., Bethea, S. F., Ingram, J. A., Zinchenko, N., & Hanley, E. N. (2011) · The Spine Journal · doi:10.1016/j.spinee.2011.06.012 · Cited by 52
“Mitochondrial dysfunction and oxidative stress are now known to be key underlying problems in cell senescence and aging [21–27].”
BackgroundZhang, L., Guan, Q., Wang, Z., Feng, J., Zou, J., & Gao, B. (2023) · Aging and Disease · doi:10.14336/ad.2023.1115 · Cited by 89
“In addition, mitochondrial ROS can damage nuclear DNA, thus activating the DNA damage response that induces senescence [209, 210].”
Senolytic therapeutics: An emerging treatment modality for osteoarthritis
Ansari, M. M., Ghosh, M., Lee, D., & Son, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102275 · Cited by 57
Oxidative stress and cell senescence as drivers of ageing: Chicken and egg
von Zglinicki, T. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102558 · Cited by 61
TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence
Kretová, M., Sabová, L., Hodný, Z., Bártek, J., Kollárovič, G., Nelson, B. D., Hubáčková, S., & Luciaková, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.029 · Cited by 46
José, C., Melser, S., Bénard, G., & Rossignol, R. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 53
“Already in 1999, Onhami and coworkers showed that the blockade of K-Ras with antisense in pancreatic cancer cells modified (increased) the expression pattern of 11 mitochondrial genes (197).”
InfluentialKeeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 46
Circumventing senescence is associated with stem cell properties and metformin sensitivity
Deschênes‐Simard, X., Parisotto, M., Rowell, M., Le Calvé, B., Igelmann, S., Moineau‐Vallée, K., Saint‐Germain, E., Kalegari, P., Bourdeau, V., Kottakis, F., et al. (2019) · Aging Cell · doi:10.1111/acel.12889 · Cited by 45
Self-citationRole of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma
Böhme, I., Lörentz, S., & Bosserhoff, A. (2022) · Cancers · doi:10.3390/cancers14092151 · Cited by 63
“Another possible mechanism by which SNAT1 regulates senescence might involve ROS, which is a critical mediator of senescence [32,33].”
BackgroundOxidative stress-induced senescence markedly increases disc cell bioenergetics
Patil, P. R., Falabella, M., Saeed, A., Lee, D., Kaufman, B. A., Shiva, S., Croix, C. M. S., Houten, B. V., Niedernhofer, L. J., Robbins, P. D., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.04.006 · Cited by 46
Cho, Y., & Kim, Y. K. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103212 · Cited by 52
Matched and mismatched metabolic fuels in lymphocyte function
Caro‐Maldonado, A., Gerriets, V. A., & Rathmell, J. C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.002 · Cited by 47
Autophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43
“During oncogene-induced senescence, genotoxic stress-induced senescence, and replicative senescence, the glycolysis level is increased [132].”
BackgroundMitochondrial Control and Guidance of Cellular Activities of T Cells
Chao, T. H., Wang, H., & Ho, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00473 · Cited by 51
“The mitochondrial free radical theory of aging has been recognized for decades (64); oxidation of cellular macromolecules and mitochondrial DNA damages are thought to be mainly caused by reactive oxygen species (ROS) produced from dysfunctional mitochondria (65, 66).”
BackgroundKuo, M.-L., Sy, A. J., Xue, L., Chi, M., Lee, M. T. C., Yen, T., Chiang, M.-I., Chang, L., Chu, P. G., & Yen, Y. (2012) · Scientific Reports · doi:10.1038/srep00822 · Cited by 51
Metabolic alterations accompanying oncogene-induced senescence
Aird, K. M., & Zhang, R. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963481 · Cited by 39
“Increased levels of fatty acids and their subsequent degradation, leading to increased NADPH levels, may occur because of an increased need for antioxidants to combat the high levels of reactive oxygen species (ROS) observed during OIS.(39,61) Interestingly, changes in fatty acid oxidation were shown to play a role in…”
BackgroundBaptiste, B. A., Katchur, S. R., Fivenson, E. M., Croteau, D. L., Rumsey, W. L., & Bohr, V. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.094 · Cited by 45
“The cell plates were incubated for 20min at room temperature in the dark, rinsed with media and stained for 8-oxoGua using methods adapted from previous methods [23-25].”
Strzeszewska, A., Alster, O., Mosieniak, G., Ciolko, A., & Sikora, E. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0069-5 · Cited by 47
Mitochondrial Bioenergetics and Dynamics in Secretion Processes
Martínez, J., Marmisolle, I., Tarallo, D., & Quijano, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00319 · Cited by 46
Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Udomsinprasert, W., Sobhonslidsuk, A., Jittikoon, J., Honsawek, S., & Chaikledkaew, U. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992385 · Cited by 43
Moiseeva, O. V., Bourdeau, V., Vernier, M., Dabauvalle, M., & Ferbeyre, G. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00719.x · Cited by 49
“Finally, lamin A ⁄ C depletion leads to a mitochondrial dysfunction phenotype (Passos et al., 2007; Moiseeva et al., 2009) characterized by high levels of ROS (reactive oxygen species) production (Fig.”
BackgroundMethodInfluentialSelf-citationAydin, E., Hallner, A., Wiktorin, H. G., Staffas, A., Hellstrand, K., & Martner, A. (2018) · Oncogene · doi:10.1038/s41388-018-0528-1 · Cited by 42
Nacarelli, T., Azar, A., & Sell, C. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00122 · Cited by 38
“In addition, rapamycin treated cultures displayed an increase in mitochondrial biogenesis and a reduction in the mitochondrial membrane depolarization that we and others have observed at higher population doublings in human fibroblasts (29, 42).”
BackgroundRai, P. (2012) · Small GTPases · doi:10.4161/sgtp.19556 · Cited by 38
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Pardella, E., Pranzini, E., Nesi, I., Parri, M., Spatafora, P., Torre, E., Muccilli, A., Castiglione, F., Fambrini, M., Sorbi, F., et al. (2022) · Cells · doi:10.3390/cells11244026 · Cited by 43
Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 63
“Genetic or pharmacological disruption of complex I 56,61 , com-plexII 68 ,andcomplexIII 56,69 inducessenescence,andcomplexIVde fi ciency is a feature of senescent cells 70,71 .”
Mitochondria, its DNA and telomeres in ageing and human population
Zole, E., & Ranka, R. (2018) · Biogerontology · doi:10.1007/s10522-018-9748-6 · Cited by 43
“Mitochondrial dysfunction leads to perturbations on the electron transport chain resulting in increased ROS generation and reductions in ATP level (Balaban et al. 2005; Moiseeva et al. 2009).”
BackgroundBarbouti, A., Lаgopati, N., Veroutis, D., Goulas, V., Evangelou, K., Kanavaros, P., Gorgoulis, V. G., & Galaris, D. (2021) · Antioxidants · doi:10.3390/antiox10030491 · Cited by 46
“trigger the activation of the p16INK4aINK4A axis and result in the induction of cell senescence [64,65,92,96].”
BackgroundRole of Oxidative Stress in the Senescence Pattern of Auditory Cells in Age-Related Hearing Loss
Chacón, L. D. M. R., Martínez-Rodríguez, S., Madrid, R., Yanes‐Diaz, J., Riestra‐Ayora, J., Fernández, R. S., & Sánchez‐Rodríguez, C. (2021) · Antioxidants · doi:10.3390/antiox10091497 · Cited by 42
“In general, the number of mitochondria increases in senescent cells [17,26,27].”
BackgroundTseng, H.-Y., Liu, Z., & Huang, H. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0856-9 · Cited by 38
“It might also be due to the oncogene-induced senescence or replicative senescence, which serves as a fail-safe action again transformation of oncogenes (Campisi 2005; Moiseeva et al. 2009).”
BackgroundEffects of cellular senescence on metabolic pathways in non-immune and immune cells
Frasca, D., Saada, Y. B., Garcia, D., & Friguet, B. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111428 · Cited by 36
“Results have shown that mitochondrial dysfunction, characterized by high production of reactive oxygen species (ROS) and depolarized mitochondria accumulating around the nucleus, drives oncogene-induced senescence via a mechanism mediated by p53 (Moiseeva et al., 2009), whose sustained activation is strictly dependent…”
BackgroundInhibiting HIF-1 signaling alleviates HTRA1-induced RPE senescence in retinal degeneration
Xu, W., Liu, X., Han, W., Wu, K., Zhao, M., Mei, T., Shang, B., Wu, J., Luo, J., Lai, Y., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01138-9 · Cited by 37
“and promoted glycolysis in ARPE‐19 cells Mitochondrial dysfunction is a hallmark of cellular senescence which contributes to the senescence growth arrest, SASP development and resistance to cell death [22, 23].”
BackgroundSubedi, S., Guntipally, M., Suwal, N., Thapa, R., Bashyal, S., Panth, N., Gupta, G., MacLoughlin, R. J., Oliver, B. G. G., Dua, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102813 · Cited by 40
Wen, Y., & Herbert, M. R. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.05.004 · Cited by 34
“signaling pathways (62), also discussed above as associated with both autism and cancer.”
BackgroundGingerenone A Induces Antiproliferation and Senescence of Breast Cancer Cells
Yu, T., Tang, J., Shiau, J., Hou, M., Yen, C., Ou‐Yang, F., Chen, C., & Chang, H. (2022) · Antioxidants · doi:10.3390/antiox11030587 · Cited by 36
“For example, oncogenic RAS upregulating mitochondrial mass and ROS can induce DNA damage and senescence [52].”
BackgroundSenescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
Özdemir, A., Demir, Y. D. Ş., Yeşilyurt, Z. E., & Ark, M. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.002 · Cited by 36
Ruan, Y., Wu, S., Zhang, L., Chen, G., & Lai, W. (2014) · Biogerontology · doi:10.1007/s10522-014-9507-2 · Cited by 34
Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP)
Malaquin, N., Tu, V., & Rodier, F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_6 · Cited by 39
Mitochondria pleiotropism in stem cell senescence: Mechanisms and therapeutic approaches
Mas‐Bargues, C. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.019 · Cited by 38
Modulation of vascular endothelial cell senescence by integrin β4
Sun, C., Liu, X., Qi, L., Xu, J., Zhao, J., Zhang, Y., Zhang, S., & Miao, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22262 · Cited by 33
“Previously, we showed that integrin b4 was involved in VEC senescence by affecting the levels of PC-PLC, p53 and ROS (Liu et al., 2007).”
BackgroundInfluentialLee, I., Park, C., & Kang, W. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0511 · Cited by 34
XPO7 is a tumor suppressor regulating p21CIP1-dependent senescence
Innes, A. J., Sun, B., Wagner, V., Brookes, S., McHugh, D., Pombo, J., Porreca, R. M., Dharmalingam, G., Vernia, S., Zuber, J., et al. (2021) · Genes & Development · doi:10.1101/gad.343269.120 · Cited by 30
“However, other studies have also made the case for the contribution of telomere-independent mechanisms, such as the production of reactive oxygen species (Takahashi et al. 2006; Moiseeva et al. 2009; Correia-Melo et al. 2016).”
BackgroundThe Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A., & Titorenko, V. I. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 30
“Some stresses can trigger a mode of cellular senescence known as premature or stress-induced senescence; these stresses include: (1) an accumulation of unrepaired damage to chromosomal DNA and the resulting genomic damage at non-telomeric sites; (2) chromatin remodeling resulting in heterochromatin foci formation and…”
BackgroundInfluentialAntagonistic TSC22D1 variants control BRAFE600‐induced senescence
Cornelia, H.-H., van Doorn, R., Vogel, C., Germann, M., Cecchini, M. G., Verdegaal, E. M. E., & Peeper, D. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.95 · Cited by 31
“Other processes, including ER stress, reactive oxygen species pro- duction and autophagy have also been linked to senescence (Denoyelle et al, 2006; Lu and Finkel, 2008; Moiseeva et al, 2009; Young et al, 2009).”
Background
Metadata
- Authors
- Moiseeva, O., Bourdeau, V., Roux, A., Deschênes-Simard, X., & Ferbeyre, G.
- Affiliations
- Université de Montréal (CA)
- Département de Biochimie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Québec H3C 3J7, Canada
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-08-01
- Volume
- 29
- Issue
- 16
- Pages
- 4495-4507
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2725737
- OpenAlex
- W2007244362
- Semantic Scholar
- 0f205d3fb7be9572b5161598c2febdb513a25421
- Cited by
- 408
- References
- 52
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 28 · 2023: 32 · 2022: 29 · 2021: 28 · 2020: 36 · 2019: 28 · 2018: 25 · 2017: 22 · 2016: 25 · 2015: 16 · 2014: 25 · 2013: 12 · 2012: 22
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- oncogene-induced senescence, mitochondrial dysfunction, oncogenic Ras, reactive oxygen species, mitochondrial DNA, oxidative DNA damage, AMPK activation, p53, Rieske iron-sulfur protein, electron transport inhibition, oxidative phosphorylation, ATP depletion, mitochondrial mass
- MeSH terms
- Adenylate Kinase, Animals, Cell Cycle, Cell Line, DNA Damage, Enzyme Activation, Humans, Mitochondria, Genes, ras, Electron Transport Complex III, Cellular Senescence, Reactive Oxygen Species, Oxidative Stress, ras Proteins, Gene Expression Profiling, Genes, Mitochondrial, Membrane Potential, Mitochondrial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.